Skip to main content
. 2016 Jul 8;11(1):99–107. doi: 10.1177/1557988315596225

Table 1.

Sample Characteristics and Bivariate Analysis of PSA Screening (n = 132).

Variable Level n (%) Ever PSA
Annual PSA
% Yes χ2 % Yes χ2
Age Screened, mean (SD) Mean = 57 57.7 (4.9) −2.10(t) 58.2 (5.2) −1.03(t)
Not screened, mean (SD) SD = 5.0 55.8 (5.1) 57.1 (4.4)
Marital status Married 28 (21%) 75% 1.98 57% 0.00
Not married 104 (79%) 60% 57%
Education level ≥Some college 65 (49%) 74% 5.77* 58% 0.06
≤High school 67 (51%) 54% 56%
Employment status Employed 36 (27%) 75% 2.72 41% 4.37*
Not employed 96 (73%) 59% 65%
Income level >$20,000 71 (55%) 77% 13.9*** 56% 0.06
≤$20,000 59 (45%) 46% 59%
Health insurance Yes 93 (70%) 67% 1.25 67% 10.86**
No 39 (30%) 56% 27%
HCP communication about PSA Yes 89 (69%) 79% 28.2*** 57% 0.21
No 40 (31%) 30% 50%
Knowledge about PC screening recommendation Correct 48 (36%) 54% 2.92 50% 0.78
Incorrect 84 (64%) 69% 60%
Exposure to PC information A fair amount/a lot 97 (73%) 70% 6.61** 62% 3.11
Almost nothing 35 (27%) 46% 38%
Perceived risk of PC Higher/much higher risk 37 (28%) 59% 0.29 64% 0.49
Same/lower risk 93 (72%) 64% 55%
Control over PC Moderate amount/a lot 70 (54%) 64% 0.01 51% 1.22
A little/none at all 60 (46%) 63% 63%
Thoughts about PC Moderate amount/a lot 31 (23%) 64% 0.01 50% 0.55
A little/not at all 101 (77%) 63% 59%
Future temporal orientation Screened, mean (SD) Mean = 3.3 14.2 (1.8) 1.80(t) 3.2 (0.61) 1.58(t)
Not screened, mean (SD) SD = 0.60 14.8 (1.7) 3.4 (0.49)
Collective efficacy Screened, mean (SD) Mean = 14.5 3.3 (0.57) −0.11(t) 14.5 (1.6) −1.41(t)
Not screened, mean (SD) SD = 1.8 3.3 (0.62) 13.9 (2.1)

Note. PSA = prostate-specific antigen; SD = standard deviation; HCP = health care provider; PC = prostate cancer.

p < .10. *p < .05.